Engineering Plasmid‐Free Escherichia coli via Synergistic Metabolic Tuning and Fermentation Optimization for High‐Titer Salidroside Biosynthesis
Biotechnology and Bioengineering · 2026-04 · 123 (4) · 1011-1021
DOI: 10.1002/bit.70153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 08.01.2026. Verfasst von Man Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Bioorganic Synthesis, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, People's R…. Hauptthemen laut MEDLINE: Glucosides, Metabolic Engineering, Escherichia coli, Phenols. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Key Research Foundation of Science and Technology Department of Zhejiang Province.
Abstract (Originalsprache)
Salidroside, a major bioactive component of Rhodiola rosea , exhibits diverse pharmacological activities and broad applications, but faces biosynthesis challenges. Herein, we developed a synergistic strategy to construct a high‐level plasmid‐free salidroside production strain W6U4. First, multi‐copy genomic integration of the phenylpyruvate decarboxylase mutant ARO10 D331C and glycosyltransferase UGT85A1 was performed to enhance precursor tyrosol synthesis and glycosylation efficiency. Subsequently, systematic metabolic engineering was applied to redirect metabolic flux: reinforcing the pentose phosphate and shikimate pathways and eliminating competing pathways, which boosted salidroside titer to 2.63 g/L in shake flasks. Finally, optimized fed‐batch fermentation in a 5‐L bioreactor with two‐stage temperature control (37°C for growth, 30°C for induction) and early log‐phase induction (OD 600 = 15) resulted in 33.68 g/L salidroside, the highest reported titer to date, with only 0.40 g/L residual tyrosol. This integrated strategy establishes an efficient, stable microbial platform for salidroside production, highlighting the synergistic effect in advancing industrial‐scale biosynthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Bioorganic Synthesis, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, People's Republic of China.
- The National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, People's Republic of China.
- State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, People's Republic of China.
ORCID-Profile: Man Zhao, Zhiqiang Liu
Förderung
- Key Research Foundation of Science and Technology Department of Zhejiang Province
Zitieren
APA
Zhao, M., Liu, K., Chen, X., Zheng, G., Liu, Z., & Zheng, Y. (2026). Engineering Plasmid‐Free Escherichia coli via Synergistic Metabolic Tuning and Fermentation Optimization for High‐Titer Salidroside Biosynthesis. Biotechnology and Bioengineering, 123(4), 1011-1021. https://doi.org/10.1002/bit.70153
Vancouver
Zhao M, Liu K, Chen X, Zheng G, Liu Z, Zheng Y. Engineering Plasmid‐Free Escherichia coli via Synergistic Metabolic Tuning and Fermentation Optimization for High‐Titer Salidroside Biosynthesis. Biotechnology and Bioengineering. 2026;123(4):1011-1021. doi:10.1002/bit.70153
BibTeX
@article{Zhao2026,
author = {Zhao, Man and Liu, Kerui and Chen, Xingyu and Zheng, Guofei and Liu, Zhiqiang and Zheng, Yuguo},
title = {Engineering Plasmid‐Free Escherichia coli via Synergistic Metabolic Tuning and Fermentation Optimization for High‐Titer Salidroside Biosynthesis},
journal = {Biotechnology and Bioengineering},
year = {2026},
volume = {123},
number = {4},
pages = {1011--1021},
doi = {10.1002/bit.70153}
}
EUVIMED